These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 30093907)
21. Editorial: Tissue Resident Memory T Cells. Mami-Chouaib F; Tartour E Front Immunol; 2019; 10():1018. PubMed ID: 31191515 [No Abstract] [Full Text] [Related]
22. Tissue-resident memory CD103+CD8+ T cells in colorectal cancer: its implication as a prognostic and predictive liver metastasis biomarker. Liu S; Wang P; Wang P; Zhao Z; Zhang X; Pan Y; Pan J Cancer Immunol Immunother; 2024 Jul; 73(9):176. PubMed ID: 38954030 [TBL] [Abstract][Full Text] [Related]
23. Resident Memory T Cells in the Tumor Microenvironment. Williams JB; Kupper TS Adv Exp Med Biol; 2020; 1273():39-68. PubMed ID: 33119875 [TBL] [Abstract][Full Text] [Related]
25. Tumor-resident memory T cells as a biomarker of the response to cancer immunotherapy. Damei I; Trickovic T; Mami-Chouaib F; Corgnac S Front Immunol; 2023; 14():1205984. PubMed ID: 37545498 [TBL] [Abstract][Full Text] [Related]
27. Optimizing the spatial immune landscape of CD103 Yang G; Hu M; Cai S; Li C; Yang L; Zhao M; Jing H; Xing L; Sun X Cell Oncol (Dordr); 2024 Oct; 47(5):1957-1971. PubMed ID: 39158668 [TBL] [Abstract][Full Text] [Related]
28. High proportion of PD-1 and CD39 positive CD8+ tissue resident T lymphocytes correlates with better clinical outcome in resected human oesophageal adenocarcinoma. Hill SL; Sugiyarto G; Harrington J; James E; Underwood TJ; Elliott T Cancer Immunol Immunother; 2024 Sep; 73(11):213. PubMed ID: 39235606 [TBL] [Abstract][Full Text] [Related]
29. CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder. Wang B; Wu S; Zeng H; Liu Z; Dong W; He W; Chen X; Dong X; Zheng L; Lin T; Huang J J Urol; 2015 Aug; 194(2):556-62. PubMed ID: 25752441 [TBL] [Abstract][Full Text] [Related]
31. CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy. Komdeur FL; Wouters MC; Workel HH; Tijans AM; Terwindt AL; Brunekreeft KL; Plat A; Klip HG; Eggink FA; Leffers N; Helfrich W; Samplonius DF; Bremer E; Wisman GB; Daemen T; Duiker EW; Hollema H; Nijman HW; de Bruyn M Oncotarget; 2016 Nov; 7(46):75130-75144. PubMed ID: 27650547 [TBL] [Abstract][Full Text] [Related]
32. Targeting Resident Memory T Cells for Cancer Immunotherapy. Blanc C; Hans S; Tran T; Granier C; Saldman A; Anson M; Oudard S; Tartour E Front Immunol; 2018; 9():1722. PubMed ID: 30100906 [TBL] [Abstract][Full Text] [Related]
33. PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer. Webb JR; Milne K; Nelson BH Cancer Immunol Res; 2015 Aug; 3(8):926-35. PubMed ID: 25957117 [TBL] [Abstract][Full Text] [Related]
34. Tumor Resident Memory T Cells: New Players in Immune Surveillance and Therapy. Dumauthioz N; Labiano S; Romero P Front Immunol; 2018; 9():2076. PubMed ID: 30258445 [TBL] [Abstract][Full Text] [Related]
35. Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity. Molodtsov A; Turk MJ Front Immunol; 2018; 9():2810. PubMed ID: 30555481 [TBL] [Abstract][Full Text] [Related]
36. CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma. Workel HH; Komdeur FL; Wouters MC; Plat A; Klip HG; Eggink FA; Wisman GB; Arts HJ; Oonk MH; Mourits MJ; Yigit R; Versluis M; Duiker EW; Hollema H; de Bruyn M; Nijman HW Eur J Cancer; 2016 Jun; 60():1-11. PubMed ID: 27038842 [TBL] [Abstract][Full Text] [Related]